İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025 · article

Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes

Dergi Viruses
ISSN1999-4915
YÖKSİS OpenAlex Açık erişim · gold
Yıl2025
Atıf0OpenAlex
Yüzdelik%55,4
FWCI0,01,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıViruses
  • Katalog eşleşmesi (ISSN)Viruses
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

This study examined the long-term transcriptomic reprogramming in peripheral blood mononuclear cells (PBMCs) of severe COVID-19 patients and its effects for cancer development. RNA sequencing was conducted on PBMCs obtained from healthy controls, COVID-19 patients without pneumonia, and COVID-19 patients exhibiting severe pneumonia one year post-infection. Differential gene expression analysis identified a sustained pro-oncogenic molecular signature, especially among severe COVID-19 patients. Functional enrichment analysis revealed a substantial enrichment of cancer-associated pathways, encompassing apoptosis, viral carcinogenesis, and transcriptional dysregulation. Notably, the autophagy-related gene SQSTM1/P62 was recognized as a distinctive hub gene within the severe COVID-19 patients, interacting with pivotal genes associated with inflammation, apoptosis, and cancer advancement. Survival analysis demonstrated that elevated expression of COVID-19-associated hub genes correlated with unfavorable prognosis in various cancer types, including adrenocortical carcinoma, bladder urothelial carcinoma, and brain lower-grade glioma. These findings indicate that severe COVID-19 infection may establish a systemic milieu favorable to cancer development or recurrence, highlighting the necessity of prolonged oncological monitoring in these patients. Finding specific molecular targets and pathways can help us understand how COVID-19 might be linked to a higher risk of cancer.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

0atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yazarlar

39
  1. PELİN DURU ÇETİNKAYA 1
  2. ÖZGECAN KAYALAR 2
  3. VAHAP ELDEM 3
  4. SERAP ARGUN BARIŞ 4
  5. NURDAN KÖKTÜRK 5
  6. Selim Can Kuralay 6
  7. Hadi Rajabi 7
  8. Nur Konyalılar 8
  9. deniz mortazavi mortazavi 9
  10. Seval Kubra Korkunc 10
  11. SİNEM ERKAN 11
  12. GİZEM TUSE AKSOY 12
  13. Gul Eyikudamaci 13
  14. PELİN PINAR DENİZ 14
  15. OYA BAYDAR TOPRAK 15
  16. PINAR YILDIZ 16
  17. GÜLSEREN SAĞCAN 17
  18. NESLİHAN KÖSE KABİL YALOVA ÜNİVERSİTESİ 18
  19. AYŞEGÜL TOMRUK ERDEM 19
  20. FÜSUN FAKILI 20
  21. ÖNDER ÖZTÜRK 21
  22. İLKNUR BAŞYİĞİT 22
  23. HAŞİM BOYACI 23
  24. EMEL AZAK KARALİ 24
  25. TANSU ULUKAVAK ÇİFTÇİ 25
  26. İPEK KIVILCIM OĞUZÜLGEN 26
  27. HASAN SELÇUK ÖZGER 27
  28. PINAR AYSERT YILDIZ 28
  29. İSMAİL HANTA 29
  30. ÖZLEM ATAOĞLU DÜZCE ÜNİVERSİTESİ 30
  31. MERVE ERÇELİK KONCAK 31
  32. ÇAĞLAR ÇUHADAROĞLU 32
  33. HACER KUZU OKUR 33
  34. MÜGE MELTEM TOR 34
  35. ESRA NURLU TEMEL 35
  36. SEVAL KUL HALTER 36
  37. YILDIZ TÜTÜNCÜ 37
  38. BAHRİYE OYA İTİL 38
  39. HASAN BAYRAM 39